Pharmanutra Logo

Pharmanutra

Develops and distributes nutritional supplements and medical devices based on research.

PHN | XMIL

Overview

Corporate Details

ISIN(s):
IT0005274094
LEI:
815600F8217BC7733697
Country:
Italy
Address:
VIA CAMPODAVELA, 1, 56122 PISA

Description

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-05-12 10:28
CS - PHN Deposito Resoconto Intermedio di gestione al 31 marzo 2022
Italian 171.4 KB
2022-05-12 10:28
PR - PHN Interim financial report as of 31 March 2022
English 169.8 KB
2022-05-09 17:37
PR PHARMANUTRA - Approval of interim report as of 31 march 2022
English 264.3 KB
2022-05-09 17:36
CS PHARMANUTRA - Approvazione resoconto intermedio di gestione al 31 marzo 2022
Italian 263.4 KB
2022-05-02 12:23
PHN_Rendiconto votazioni_assemblea azionisti 27042022
Italian 155.8 KB
2022-05-02 12:21
PHARMANUTRA_PR Synthetic report on voting results
English 170.6 KB
2022-05-02 12:19
PHARMANUTRA - CS Rendiconto sintetico delle votazioni
Italian 184.6 KB
2022-04-27 16:22
PHN_PR Resolutions of the ordinary Shareholders' meeting 27_04_2022
English 193.2 KB
2022-04-27 16:20
PHN_CS - Delibere dell'Assemblea degli Azionisti
Italian 216.3 KB
2022-04-11 15:33
Allegati 3F - Marzo 2022
Italian 63.1 KB
2022-04-06 18:29
Lista per la nomina del Collegio Sindacale
Italian 7.9 MB
2022-04-06 18:02
Explanatory Memorandum on Authorisation to purchase and use trasury shares
English 413.2 KB
2022-04-06 18:00
Relazione illustrativa del Consiglio di Amministrazione sul programma di acquis…
Italian 416.9 KB
2022-04-06 17:58
REPORT ON THE REMUNERATION POLICY AND THE REMUNERATION PAID
English 539.6 KB
2022-04-06 17:57
RELAZIONE SULLA POLITICA DI REMUNERAZIONE E SUI COMPENSI CORRISPOSTI
Italian 510.1 KB

Automate Your Workflow. Get a real-time feed of all Pharmanutra filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmanutra

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmanutra via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.